Indonesia approves Sinopharm Covid-19 vaccine for emergency use | World

Friday, 30 Apr 2021 03:25 PM MYT
After Sinovac Biotech and AstraZeneca, Sinopharm is the third company to have its vaccine approved by Indonesia, which is seeking to inoculate 181.5 million people by January 2022. — Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
JAKARTA, April 30 ― Indonesia's drug regulator today approved the Covid-19 vaccine of China's Sinopharm, which it will use in a private immunisation scheme where companies buy government-procured vaccines to inoculate their staff.
After Sinovac Biotech and AstraZeneca, Sinopharm is the third company to have its vaccine approved by Indonesia, which is seeking to inoculate 181.5 million people by January 2022.

Related Keywords

Beijing ,China ,Indonesia ,India ,Jakarta ,Jakarta Raya ,Budi Gunadi Sadikin ,Verdi Budidarmo ,Kimia Farma ,Astrazeneca ,Sinovac Biotech ,China National Biotec Group ,Products Institute ,Reuters ,After Sinovac Biotech ,Beijing Biological Products Institute ,Covid 19 ,Covid 19 Vaccine ,Inopharm ,பெய்ஜிங் ,சீனா ,இந்தோனேசியா ,இந்தியா ,ஜகார்த்தா ,ஜகார்த்தா ராய ,கிமீய பண்ணை ,சீனா தேசிய பயோடெக் குழு ,ப்ராடக்ட்ஸ் நிறுவனம் ,ராய்ட்டர்ஸ் ,பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் ,விட் ,விட் தடுப்பூசி ,